CALABRESE, Cecilia
 Distribuzione geografica
Continente #
EU - Europa 2.058
NA - Nord America 1.914
AS - Asia 358
SA - Sud America 18
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.363
Nazione #
US - Stati Uniti d'America 1.908
IE - Irlanda 737
IT - Italia 326
UA - Ucraina 291
GB - Regno Unito 236
DE - Germania 195
CN - Cina 166
SG - Singapore 114
SE - Svezia 84
FI - Finlandia 79
GR - Grecia 54
TR - Turchia 52
FR - Francia 26
BE - Belgio 16
SC - Seychelles 12
BR - Brasile 11
CO - Colombia 7
IN - India 7
KR - Corea 6
CA - Canada 5
NL - Olanda 4
ID - Indonesia 3
AT - Austria 2
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
JP - Giappone 2
RO - Romania 2
VN - Vietnam 2
AU - Australia 1
CH - Svizzera 1
IR - Iran 1
LB - Libano 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 4.363
Città #
Dublin 737
Jacksonville 456
Chandler 318
Princeton 111
Bremen 110
Roxbury 98
Ann Arbor 90
Medford 62
Cambridge 61
Wilmington 59
Singapore 51
Boardman 41
Houston 41
Mountain View 32
Woodbridge 30
Beijing 28
Ashburn 24
Caserta 23
San Mateo 23
Bari 21
Jinan 21
New York 18
Des Moines 17
Brussels 16
Naples 16
Rome 14
Marano Di Napoli 13
Shenyang 13
Fuzhou 12
Nanchang 9
Nanjing 9
Napoli 9
Guangzhou 8
Tianjin 8
Düsseldorf 7
Ningbo 7
Putian 7
Cursi 6
Helsinki 6
Nuremberg 6
Villaricca 6
Changsha 5
Fisciano 5
Hangzhou 5
Milan 5
Norwalk 5
Redwood City 5
Casavatore 4
Istanbul 4
Lappeenranta 4
Pozzuoli 4
Putignano 4
Santeramo in Colle 4
Taiyuan 4
Zhengzhou 4
Borås 3
Boydton 3
Jakarta 3
Lanzhou 3
Los Angeles 3
Seattle 3
Sommatino 3
Taizhou 3
Venice 3
Alessandria 2
Arad 2
Auburn Hills 2
Avellino 2
Aversa 2
Bologna 2
Brescia 2
Brno 2
Chungcheongnam-do 2
Como 2
Crotone 2
Dearborn 2
Dong Ket 2
Elora 2
Ercolano 2
Fairfield 2
Falls Church 2
Foz Do Iguaçu 2
Frankfurt am Main 2
Haikou 2
Hebei 2
Hefei 2
Hong Kong 2
Kunming 2
Limatola 2
Mangalore 2
Monza 2
Noicattaro 2
Nola 2
Palermo 2
Paris 2
Pellezzano 2
Round Rock 2
San Giuseppe Vesuviano 2
San Valentino Torio 2
Santa Clara 2
Totale 2.805
Nome #
Tollerabilità del GSH inalatorio in pazienti pediatrici e adulti con fibrosi cistica 118
Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans 79
A CASE OF A PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA TRANSFORMED INTO AN EPITHELIOID ANGIOSARCOMA 77
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction 75
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages 75
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 69
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 69
Immunoflogosi nell’Asma Bronchiale 65
Lung mast cells are a source of secreted phospholipases A(2). 63
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. 62
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 61
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma 58
[Clinical use of recombinant IFN alfa-2b in the treatment of primary cancer of the lung (preliminary results)] 58
ANGIOGENETIC AND APOPTOTIC PROCESS IN THE AIRWAYS OF SYMPTOMATIC SMOKERS WITH AND WITHOUT A CONTRALATERAL NON SMALL CELL LUNG CANCER 58
VASCULAR REMODELLING IN BRONCHIAL MUCOSA OF SMOKERS WITH AND WITHOUT AIRWAY OBSTRUCTION 58
L'ASMA GRAVE: FENOTIPI CLINICI 57
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease. 55
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 55
Application of proteomics and peptidomics to COPD. 55
Dupilumab: A novel treatment for asthma 55
CORRELAZIONI TRA CELLULARITA' E MEDIATORI CHIMICI NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE IN PAZIENTI CON ASMA BRONCHIALE ATOPICO 54
T cell activation state in the induced sputum of asthmatics treated with budesonide 54
ANGIOGENESIS IN BRONCHIAL BIOPSIES OF SYMPTOMATIC SMOKERS WITH AND WITHOUT LUNG CANCER 54
Obstructive sleep apnea and cardiovascular risks in the elderly population 54
Basophil activation test for staphylococcus enterotoxins in severe asthmatic patients 54
Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort 53
CARATTERISTICHE CLINICHE E MONITORAGGIO DEI PAZIENTI AFFETTI DA ASMA BRONCHIALE GRAVE DI DIFFICILE CONTROLLO 52
A CASE OF DOUBLE AORTIC ARCH SUGGESTED BY THE ANALYSIS OF THE FLOW-VOLUME CURVE 52
BRONCHIAL VASCULARITY IN THE AIRWAYS OF CHRONIC BRONCHITIS AND COPD SMOKERS 51
MONITORAGGIO CLINICO E IMMUNOLOGICO DI UN GRUPPO DI PAZIENTI AFFETTI DA ASMA BRONCHIALE ATOPICO O ASMA BRONCHIALE E RINITE ALLERGICA IN TRATTAMENTO IPOSENSIBILIZZANTE SPECIFICO PER VIA SOTTOCUTANEA OD ORALE 50
New perspectives in asthma treatment 49
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma 49
ANTAGONISTI DEI LEUCOTRIENI E DI ALTRI MEDIATORI LIPIDICI 48
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 48
FARMACI ATTIVI SUI MECCANISMI DELLA FLOGOSI 47
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 46
Asma e gravidanza 46
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients 46
NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures 46
Role of monocyte/macrophage population in immune response 45
INFLUENZA DELL'INQUINAMENTO AMBIENTALE SULLA FUNZIONE RESPIRATORIA 45
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 45
AGONISTI BETA2-ADRENERGICI 45
Inhibition of Cytosolic Phospholipase A2 in Human Neutrophils by Oxatomide 44
Risultati preliminari sull'impiego della picotamide monoidrata in pazienti asmatici 43
Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis 43
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 43
CYTOFLUORIMETRIC ANALYSIS OF CYTOKINE-PRODUCING LYMPHOCYTES IN BAL FROM TB PATIENTS 42
IFNg triggers apoptosis in vitro M.T. activated alveolar macrophages 42
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 42
IL POLMONE NELL'ARTRITE REUMATOIDE E NEL LUPUS ERITEMATOSO SISTEMICO 41
Effetti della stimolazione nasale con estratto di parietaria sui livelli di no esalato in pazienti con rinite allergica intermittente 41
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 40
EVALUATION OF THE EFFICIENCY OF CORTICOSTEROID (BECLOMETIIASONE-DIPROPRIONATE) USE IN ATOPIC PATIENTS WITH MILD ASTHMA 40
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 40
ASMA E MENOPAUSA 39
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma 39
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis 39
PHENOTYPIC FEATURES AND ACTIVATION OF ALVEOLAR MACROPHAGES IN ATOPIC ASTHMATIC PATIENTS 38
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 38
The serum metabolome of moderate and severe covid-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism 38
NEUROPEPTIDE EXPRESSION IN THE AIRWAYS OF COPD PATIENTS AND SMOKERS WITH NORMAL LUNG FUNCTION. 37
FIBROBLAST PROLIFERATION INDUCED BY GROWTH FACTORS IN DIOPATHIC PULMONARY FIBROSIS 37
A storm of stones in the lungs: an uncommon sequela of varicella pneumonia 37
SCHEMI DI TERAPIA DELL'ASMA BRONCHIALE 36
Vascular remodelling in COPD airways 36
Association between exhaled nitric oxide and nasal polyposis in severe asthma 36
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers. 34
Lipid mediators from mast cells and basophils in allergic diseases 34
FARMACI ANTIMUSCARINICI 34
S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review 33
Inibitori delle molecole di adesione 33
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 33
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 33
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 32
Tiotropium Respimat Inhaler and the Risk of Death in COPD 32
Inibitori dei Fattori di crescita 32
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms 32
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 31
METABOLISM OF LIPID MEDIATORS IN HUMAN EOSINOPHILS 31
TOSSE CRONICA E MALATTIA DA REFLUSSO GASTROESOFAGEO 31
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 31
Diagnostica allergologica "in vivo" 30
CONFRONTO DEI FENOMENI DI ANGIOGENESI E DI PROLIFERAZIONE CELLULARE NELLE VIE AEREE DI FUMATORI SINTOMATICI CON E SENZA BPCO 30
IMMUNOLOGICAL INTERACTIONS BETWEEN HUMAN EOSINOPHILS AND CARDIAC MAST CELLS 29
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 27
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism 27
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 26
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 26
ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role 26
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 26
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 25
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy. 24
Novel Biological Therapies for Severe Asthma Endotypes 24
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report 23
Characteristics and treatment regimens across ERS SHARP severe asthma registries 23
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 23
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy. 21
Staphylococcus Aureus in chronic airway diseases: An overview 21
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 21
Totale 4.344
Categoria #
all - tutte 19.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020464 80 77 5 5 76 23 102 16 31 10 28 11
2020/2021758 58 2 81 53 166 16 103 76 7 106 73 17
2021/2022779 27 1 0 5 213 48 16 32 26 119 54 238
2022/20231.436 137 9 28 108 217 113 24 59 686 14 17 24
2023/2024536 49 21 25 42 187 24 26 9 6 4 51 92
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 4.621